You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 29, 2024

Details for Patent: 10,736,839

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 10,736,839 protect, and when does it expire?

Patent 10,736,839 protects ZELSUVMI and is included in one NDA.

This patent has thirteen patent family members in nine countries.

Summary for Patent: 10,736,839

Title:	Topical antiviral compositions, delivery systems, and methods of using the same
Abstract:	The present invention relates generally to topical antiviral compositions, delivery systems, and methods of using the same.
Inventor(s):	McHale Kimberly, Doxey Ryan, Stasko Nathan
Assignee:	Novan, Inc.
Application Number:	US16431214
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent 10,736,839

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Lnhc	ZELSUVMI	berdazimer sodium	GEL;TOPICAL	217424-001	Jan 5, 2024		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				METHOD OF TREATING AND/OR PREVENTING MOLLUSCUM CONTAGIOSUM WITH A NITRIC OXIDE RELEASING TOPICAL COMPOSITION	⤷ Try a Trial
Lnhc	ZELSUVMI	berdazimer sodium	GEL;TOPICAL	217424-001	Jan 5, 2024		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				METHOD OF TREATING, PREVENTING, OR REDUCING LESIONS CAUSED BY MOLLUSCUM CONTAGIOSUM	⤷ Try a Trial
Lnhc	ZELSUVMI	berdazimer sodium	GEL;TOPICAL	217424-001	Jan 5, 2024		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				METHOD OF TREATING AND/OR PREVENTING VIRAL INFECTION WITH A TOPICAL NITRIC OXIDE RELEASING COMPONENT	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 10,736,839

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2015287674	⤷ Try a Trial
Brazil	112017000456	⤷ Try a Trial
Canada	2954061	⤷ Try a Trial
China	106659675	⤷ Try a Trial
European Patent Office	3166593	⤷ Try a Trial
European Patent Office	3698775	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.